Testing effectiveness (Phase 2)Study completedNCT00331409
What this trial is testing
Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 23